Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Non-cash Items (2018 - 2024)

Historic Non-cash Items for ImmunoTech (AIM) over the last 5 years, with Q4 2024 value amounting to $2.8 million.

  • ImmunoTech's Non-cash Items rose 1737.95% to $2.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year increase of 1737.95%. This contributed to the annual value of $2.8 million for FY2024, which is 1737.95% up from last year.
  • Latest data reveals that ImmunoTech reported Non-cash Items of $2.8 million as of Q4 2024, which was up 1737.95% from $53400.0 recorded in Q3 2024.
  • In the past 5 years, ImmunoTech's Non-cash Items registered a high of $2.8 million during Q4 2024, and its lowest value of $53400.0 during Q3 2024.
  • Over the past 3 years, ImmunoTech's median Non-cash Items value was $1.0 million (recorded in 2023), while the average stood at $1.2 million.
  • Data for ImmunoTech's Non-cash Items shows a peak YoY increase of 3297.22% (in 2020) and a maximum YoY decrease of 9740.12% (in 2020) over the last 5 years.
  • Over the past 3 years, ImmunoTech's Non-cash Items (Quarter) stood at $125321.0 in 2020, then skyrocketed by 1813.07% to $2.4 million in 2023, then rose by 17.38% to $2.8 million in 2024.
  • Its Non-cash Items was $2.8 million in Q4 2024, compared to $53400.0 in Q3 2024 and $2.2 million in Q2 2024.